David Anderson II in Louisville, Kentucky

Home Kentucky Louisville

David Anderson II has Interventional Pain Management as his primary medical specialty. Their primary office is: 9702 Stonestreet Rd in Louisville, Kentucky. There is an additional office location, for a total of two, for David Anderson II that can be viewed further down.

They're a part of the: Brightview Llc medical group which has around 129 members. You can call their office at 833-510-4357 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of Louisville School Of Medicine and graduated in 2008 (around 16 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

David Michael Anderson II Office Phone and Directions

David Anderson II
Brightview Llc
9702 Stonestreet Rd
Louisville, Kentucky 40272
833-510-4357

Patient Ratings
Please rate your experience with David Anderson II below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 833-510-4357

Enter a starting address:

Healthcare Info for David Anderson II

Medical School: University Of Louisville School Of Medicine
Graduation Year: 2008
The Primary Medical Specialty for David Anderson II is listed as: Interventional Pain Management
Approximate Years of Experience: 16
PAC (PECOS ID)#: 3375784895
NPI #: 1962661488
NPI Created On: 06/09/2008
NPI Last Updated Listed as: 06/05/2023
Primary Taxonomy Code: 2083A0300X
License Number:
46107
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Celtic Insurance Company
Humana
CareSource
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Aspiration and/or injection of large joint or joint capsule
Injection of substance into spinal canal of lower back or sacrum using imaging guidance
Fluoroscopic guidance for insertion of needle
Testing for presence of drug
Testing for presence of drug
Sars-cov-2 covid-19 amp prb
Interactive complexity
Psychotherapy, 30 minutes
Group psychotherapy
Health behavior assessment, or re-assessment
New patient office or other outpatient visit, typically 30 minutes
Established patient office or other outpatient visit, typically 5 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms
Injection, methylprednisolone acetate, 40 mg
Injection, dexamethasone sodium phosphate, 1 mg
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml